Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gesine Bug

Showing results (21-30 of 165) with videos related to

Pageof 17
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2011
Enhanced immune response after a second dose of an AS03-adjuvanted H1N1 influenza A vaccine in patients after hematopoietic stem cell transplantationSaskia Gueller, Regina Allwinn, Sabine Mousset, et al.
Journal of Cellular and Molecular Medicine|March 24, 2016
CD19-CAR engineered NK-92 cells are sufficient to overcome NK cell resistance in B-cell malignanciesAnnette Romanski, Christoph Uherek, Gesine Bug, et al.
Haematologica|March 7, 2007
Arsenic but not all-trans retinoic acid overcomes the aberrant stem cell capacity of PML/RARalpha-positive leukemic stem cellsXiaomin Zheng, Anita Seshire, Brigitte Rüster, et al.
Annals of Hematology|July 8, 2005
High-dose melphalan is an effective salvage therapy in acute myeloid leukaemia patients with refractory relapse and relapse after autologous stem cell transplantationGesine Bug, Johannes Atta, Stefan A Klein, et al.
Leukemia Research|August 3, 2010
The deacetylase inhibitor LAQ824 induces notch signalling in haematopoietic progenitor cellsKerstin Schwarz, Annette Romanski, Elena Puccetti, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 23, 2022
Twenty years of experience of a tertiary cancer center in total body irradiation with focus on oncological outcome and secondary malignanciesKatharina Sieker, Maximilian Fleischmann, Martin Trommel, et al.
Frontiers in Immunology|December 31, 2024
Impact of inhibitory KIR ligand mismatch and other variables on outcomes following myeloablative posttransplant cyclophosphamide-based T-cell-replete haploidentical bone marrow transplantationSarah Kayser, Emilia Salzmann-Manrique, Hubert Serve, et al.
Haematologica|April 13, 2004
Use of a novel histone deacetylase inhibitor to induce apoptosis in cell lines of acute lymphoblastic leukemiaAnnette Romanski, Biserka Bacic, Gesine Bug, et al.
Haematologica|January 16, 2016
Interleukin-15-activated cytokine-induced killer cells may sustain remission in leukemia patients after allogeneic stem cell transplantation: feasibility, safety and first insights on efficacyEva Rettinger, Sabine Huenecke, Halvard Bonig, et al.
Cytotherapy|October 8, 2013
Treatment of patients with advanced cancer with the natural killer cell line NK-92Torsten Tonn, Dirk Schwabe, Hans G Klingemann, et al.
Pageof 17

Showing results (21-30 of 165) with videos related to

Sort By:
Pageof 17
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2011
Enhanced immune response after a second dose of an AS03-adjuvanted H1N1 influenza A vaccine in patients after hematopoietic stem cell transplantationSaskia Gueller, Regina Allwinn, Sabine Mousset, et al.
Journal of Cellular and Molecular Medicine|March 24, 2016
CD19-CAR engineered NK-92 cells are sufficient to overcome NK cell resistance in B-cell malignanciesAnnette Romanski, Christoph Uherek, Gesine Bug, et al.
Haematologica|March 7, 2007
Arsenic but not all-trans retinoic acid overcomes the aberrant stem cell capacity of PML/RARalpha-positive leukemic stem cellsXiaomin Zheng, Anita Seshire, Brigitte Rüster, et al.
Annals of Hematology|July 8, 2005
High-dose melphalan is an effective salvage therapy in acute myeloid leukaemia patients with refractory relapse and relapse after autologous stem cell transplantationGesine Bug, Johannes Atta, Stefan A Klein, et al.
Leukemia Research|August 3, 2010
The deacetylase inhibitor LAQ824 induces notch signalling in haematopoietic progenitor cellsKerstin Schwarz, Annette Romanski, Elena Puccetti, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|March 23, 2022
Twenty years of experience of a tertiary cancer center in total body irradiation with focus on oncological outcome and secondary malignanciesKatharina Sieker, Maximilian Fleischmann, Martin Trommel, et al.
Frontiers in Immunology|December 31, 2024
Impact of inhibitory KIR ligand mismatch and other variables on outcomes following myeloablative posttransplant cyclophosphamide-based T-cell-replete haploidentical bone marrow transplantationSarah Kayser, Emilia Salzmann-Manrique, Hubert Serve, et al.
Haematologica|April 13, 2004
Use of a novel histone deacetylase inhibitor to induce apoptosis in cell lines of acute lymphoblastic leukemiaAnnette Romanski, Biserka Bacic, Gesine Bug, et al.
Haematologica|January 16, 2016
Interleukin-15-activated cytokine-induced killer cells may sustain remission in leukemia patients after allogeneic stem cell transplantation: feasibility, safety and first insights on efficacyEva Rettinger, Sabine Huenecke, Halvard Bonig, et al.
Cytotherapy|October 8, 2013
Treatment of patients with advanced cancer with the natural killer cell line NK-92Torsten Tonn, Dirk Schwabe, Hans G Klingemann, et al.
Pageof 17